BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38448852)

  • 1. The Effect of chemo- and radiotherapy on tumor necrosis in soft tissue sarcoma- does it influence prognosis?
    Fromm J; Klein A; Kirilova M; Lindner LH; Nachbichler S; Holzapfel BM; Goller SS; Knösel T; Dürr HR
    BMC Cancer; 2024 Mar; 24(1):303. PubMed ID: 38448852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
    Kobus M; Roohani S; Ehret F; Flörcken A; Striefler JK; Brandes F; Märdian S; Rau D; Wittenberg S; Öllinger R; Kaul D
    Radiat Oncol; 2022 Aug; 17(1):139. PubMed ID: 35941656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
    Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
    Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy.
    Mullen JT; Hornicek FJ; Harmon DC; Raskin KA; Chen YL; Szymonifka J; Yeap BY; Choy E; DeLaney TF; Nielsen GP
    Cancer; 2014 Dec; 120(23):3676-82. PubMed ID: 25081640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma.
    Vaynrub M; Taheri N; Ahlmann ER; Yao C; Fedenko AN; Allison DC; Chawla SP; Menendez LR
    J Surg Oncol; 2015 Feb; 111(2):152-7. PubMed ID: 25175933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
    Trovik CS;
    Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study.
    Bonvalot S; Wunder J; Gronchi A; Broto JM; Turcotte R; Rastrelli M; Papai Z; Radaelli S; Lindner LH; Shumelinsky F; Cubillo A; Rutkowski P; Demaire C; Strens D; Nalbantov G
    Eur J Surg Oncol; 2021 Aug; 47(8):2166-2172. PubMed ID: 33676792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
    Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
    Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A staging system for soft-tissue sarcoma and its evaluation in relation to treatment.
    Tomita Y; Kuratsu S; Naka N; Uchida A; Ono K; Ohsawa M; Aozasa K
    Int J Cancer; 1994 Jul; 58(2):168-73. PubMed ID: 8026876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soft tissue sarcoma in children: prognosis and management.
    Koscielniak E; Morgan M; Treuner J
    Paediatr Drugs; 2002; 4(1):21-8. PubMed ID: 11817983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma.
    Gannon NP; Stemm MH; King DM; Bedi M
    J Cancer Res Clin Oncol; 2019 May; 145(5):1321-1330. PubMed ID: 30847552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis and clinical outcomes following neoadjuvant therapy in soft tissue sarcoma: A systematic review and meta-analysis.
    Salah S; Lewin J; Amir E; Abdul Razak A
    Cancer Treat Rev; 2018 Sep; 69():1-10. PubMed ID: 29843049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
    Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic Response to Neoadjuvant Therapy Is Not Predictive of Favorable Outcomes in High-grade Pleomorphic Soft Tissue Sarcoma.
    Cates JMM
    Am J Surg Pathol; 2019 Apr; 43(4):564-572. PubMed ID: 30628925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma.
    Patel R; Mowery YM; Qi Y; Bassil AM; Holbrook M; Xu ES; Hong CS; Himes JE; Williams NT; Everitt J; Ma Y; Luo L; Selitsky SR; Modliszewski JL; Gao J; Jung SH; Kirsch DG; Badea CT
    Mol Cancer Ther; 2023 Jan; 22(1):112-122. PubMed ID: 36162051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating soft tissue sarcomas with adjuvant chemotherapy.
    Patrikidou A; Domont J; Cioffi A; Le Cesne A
    Curr Treat Options Oncol; 2011 Mar; 12(1):21-31. PubMed ID: 21384115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemoradiation (modified Eilber protocol) versus adjuvant radiotherapy in the treatment of extremity soft tissue sarcoma.
    Lehane C; Ho F; Thompson SR; Links D; Lewis C; Smee R; Parasyn A; Friedlander M; Williams J; Crowe P
    J Med Imaging Radiat Oncol; 2016 Aug; 60(4):539-44. PubMed ID: 26936092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma.
    Shah D; Borys D; Martinez SR; Li CS; Tamurian RM; Bold RJ; Monjazeb A; Canter RJ
    Anticancer Res; 2012 Sep; 32(9):3911-5. PubMed ID: 22993336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
    Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
    Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological Outcome and Prognostic Factors of Surgery for Soft Tissue Sarcoma After Neoadjuvant or Adjuvant Radiation Therapy: A Retrospective Analysis over 15 Years.
    Muehlhofer HML; Schlossmacher B; Lenze U; Lenze F; Burgkart R; Gersing AS; Peeken JC; Combs SE; VON Eisenhart-Rothe R; Knebel C
    Anticancer Res; 2021 Jan; 41(1):359-368. PubMed ID: 33419832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.